Efficacy seen in phase II study of cabozantinib in refractory metastatic colorectal cancer Feb. 4, 2020
Safety and early signs of clinical efficacy for SBP-101 plus gemcitabine and nab-paclitaxel in PDA Feb. 4, 2020
Corvus offers new data from ongoing phase I/Ib trial of CPI-818 in advanced T-cell lymphomas Feb. 3, 2020
Eisai initiates phase II study of E-7090 in advanced cholangiocarcinoma with FGFR2 gene fusion Feb. 3, 2020
RSS